Yuzhiyou Biotech's stock price plummeted because the prospec...

Yuzhiyou Biotech's stock price plummeted because the prospects for commercialization of its core products were uncertain, the product market was limited, relied on financing and debt support, tight cash flow, and the risk of a liquidity crisis. In the face of intense competition in the M701 industry, it remains to be seen whether it can gain market share.